About Sol-gel (SLGL)
Sol-Gel Technologies Ltd operates as a clinical stage pharmaceutical company. The Company identifies and develops topical dermatological drug products for the treatment of skin diseases. Sol-Gel Technologies markets its products worldwide.
- USD53.62
- USD63.03
- USD48.26
- USD75.00
- 35.40%
- 19M
- 25.49k
- 19.31k
- 194M
- 4.02
- 577.10%
Stock News
3 hours ago
Oscar Mayer Wienie 500 Returns for its Second Year with a Sizzling New Twist
Yahoo
yesterday
Gold now costs more than $5,000 an ounce. Here’s how it got to this milestone price.
MarketWatch
yesterday
What I want from Apple, Meta and Microsoft in their key earnings reports
CNBC
yesterday
Alex Pretti killing: Minnesota CEOs, including UnitedHealth, Target, call for 'immediate deescalation'
CNBC